Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PD-1/PD-L1 inhibitor duration in advanced solid tumors
NCT04157985Phase 3Completed
- Start
- Nov 2019
- Primary completion
- Oct 2025
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in solid tumor (advanced stage), non-small cell lung cancer (NSCLC), bladder cancer and 11 more. Started Nov 2019; status: completed.
02
Conditions
solid tumor (advanced stage)non-small cell lung cancer (NSCLC)bladder cancerhead and neck squamous cell carcinoma (HNSCC)renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT04157985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04157985.